- Home
- PCRX vs LDP Comparison
PCRX vs LDP Comparison
Compare PCRX & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- LDP
- Stock Information
- Founded
- PCRX 2006
- LDP 2012
- Country
- PCRX United States
- LDP United States
- Employees
- PCRX N/A
- LDP N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- LDP Finance Companies
- Sector
- PCRX Health Care
- LDP Finance
- Exchange
- PCRX Nasdaq
- LDP Nasdaq
- Market Cap
- PCRX 1.2B
- LDP 599.3M
- IPO Year
- PCRX 2011
- LDP N/A
- Fundamental
- Price
- PCRX $26.09
- LDP $20.94
- Analyst Decision
- PCRX Buy
- LDP
- Analyst Count
- PCRX 10
- LDP 0
- Target Price
- PCRX $29.30
- LDP N/A
- AVG Volume (30 Days)
- PCRX 892.8K
- LDP 102.5K
- Earning Date
- PCRX 02-27-2025
- LDP 01-01-0001
- Dividend Yield
- PCRX N/A
- LDP 7.91%
- EPS Growth
- PCRX N/A
- LDP N/A
- EPS
- PCRX N/A
- LDP N/A
- Revenue
- PCRX $694,957,000.00
- LDP N/A
- Revenue This Year
- PCRX $5.14
- LDP N/A
- Revenue Next Year
- PCRX $2.44
- LDP N/A
- P/E Ratio
- PCRX N/A
- LDP N/A
- Revenue Growth
- PCRX 4.40
- LDP N/A
- 52 Week Low
- PCRX $11.16
- LDP $16.16
- 52 Week High
- PCRX $31.67
- LDP $20.30
- Technical
- Relative Strength Index (RSI)
- PCRX 77.75
- LDP 63.91
- Support Level
- PCRX $25.06
- LDP $20.61
- Resistance Level
- PCRX $27.10
- LDP $20.96
- Average True Range (ATR)
- PCRX 1.45
- LDP 0.19
- MACD
- PCRX 0.28
- LDP 0.07
- Stochastic Oscillator
- PCRX 86.23
- LDP 93.75
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.